Hematology is a clinical specialty with strong roots in the laboratory; accordingly, the lab can help solve perplexing clinical problems. This review highlights clinical-pathological conundrums addressed during my 35-year hematology career at McMaster University. Heyde syndrome is the association between
aortic stenosis and
bleeding gastrointestinal (GI)
angiodysplasia where the
bleeding is usually cured by aortic valve replacement; the chance reading of a neonatal study showing reversible deficiency of high-molecular-weight (HMW) multimers of
von Willebrand factor (vWF) following surgical correction of
congenital heart disease provided the key insight that a subtle deficiency of HMW multimers of vWF explains Heyde syndrome. The unusual immunobiology of
heparin-induced
thrombocytopenia (HIT)-a highly prothrombotic, antibody-mediated, anti-
platelet factor 4 (PF4) disorder featuring rapid appearance and then disappearance (seroreversion) of the pathological
heparin-dependent platelet-activating
antibodies-permitted identification of key clinical features that informed development of a scoring system (4Ts) to aid in HIT diagnosis. Atypical clinical presentations of HIT prompted identification of
heparin-independent anti-PF4
antibodies, now recognized as the explanation for
vaccine-induced immune thrombotic
thrombocytopenia (VITT), as well as VITT-like disorders triggered by
adenovirus infection. Another unusual feature of HIT is its strong association with limb
ischemia, including limb
necrosis secondary to deep-vein/microvascular
thrombosis (venous limb
gangrene). The remarkable observation that supratherapeutic
warfarin anticoagulation predisposes to HIT- and
cancer-associated venous limb
gangrene provided insight into disturbed procoagulant/
anticoagulant balance; these concepts are relevant to microvascular
thrombosis in
critical illness (symmetrical peripheral
gangrene), including a pathophysiological role for proximate "
shock liver" (impaired hepatic synthesis of natural
anticoagulants).